-
2025 CCHIO | CACA–AACR Summit Successfully Held, Advancing China–U.S. Collaboration in Cancer Prevention and Control
Editor’s Note On November 8, 2025, during the China Conference on Holistic and Integrative Oncology (CCHIO), the China Anti-Cancer Association (CACA) and the American Association for Cancer Research (AACR) jointly…
-
Inside a Top Journal丨Nature Medicine Editor-in-Chief João Monteiro and Professor Shanshan Pei Discuss Global and Chinese Frontiers in Medical Research
In today’s rapidly evolving biomedical landscape, cell therapy has emerged as a major breakthrough direction and a focal point of global scientific inquiry. Against this backdrop, during the 2025 International Cell and Immunotherapy Congress (CTI 2025), Professor Shanshan Pei of Liangzhu Laboratory and the First Affiliated Hospital of Zhejiang University School of Medicine engaged in a scholarly dialogue with Dr. João Monteiro, Editor-in-Chief of Nature Medicine.
-
FACO | Zhong Jianhong / Su Jiayong: The More High-Risk Factors for Hepatocellular Carcinoma Recurrence, the Greater the Need for Adjuvant Therapy?
Q: Which presentations or discussions at this year’s FACO conference left the strongest impression on you? How might they influence your clinical practice? Dr. Su Jiayong: Thank you for the…
-
2025 FACO | Prof. Chao Chen: Building a Precision Model to Guide Immunotherapy for Liver Cancer, Looking to Broaden Validation Through Collaboration
Editor’s Note: China, Japan, South Korea and other East Asian countries share a high prevalence of hepatobiliary and pancreatic tumors, yet current treatment options still fall short of clinical needs.…
Connecting Medical Expertise through Media
